N-docosanol (Abreva) for herpes labialis: Problems and questions [6]

Journal of the American Academy of Dermatology

Volumn 47, Issue 3, 2002, Pages 457-458

  Spruance, Spotswood L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; BEHENYL ALCOHOL; CORTICOSTEROID; MACROGOL; STEARIC ACID;

ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; CLINICAL TRIAL; DRUG APPROVAL; DRUG MECHANISM; FOOD AND DRUG ADMINISTRATION; GUINEA PIG; HERPES; HERPES LABIALIS; HERPES SIMPLEX; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; WOUND HEALING;

EID: 0036739057     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.122743     Document Type: Letter

References (14)

1. Sacks SL, Thisted RA, Jones T, Barbarash RA, Mikolich D, Ruoff G, et al. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: a multicenter, randomized, placebo-controlled trial. J Am Acad Dermatol 2001;45:222-30.
2. Docosanol cream becomes first OTC antiviral drug in the U.S. Antiviral Agents Bulletin 2000;13:225-6.
3. Spruance SL, McKeough MB. Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection. Arch Dermatol 2001;137: 1153-8.
4. Spruance SL, Wenerstrom G. Pathogenesis of herpes simplex labialis: IV. Maturation of lesions with 8 hours after onset and implications for antiviral treatment. Oral Surg Oral Med Oral Pathol 1984;58:667-71.
5. Sheth NV, Freeman DJ, Higuchi WI, Spruance SL. The influence of Azone, propylene glycol and polyethylene glycol on the in vitro skin penetration of trifluorothymidine. Int J Pharm 1986;28:201-9.
6. Eaglstein WH, Mertz PM. New methods for assessing epidermal wound healing: the effects of triamcinolone acetonide and polyethelene film occlusion. J Invest Dermatol 1978;71:382-4.
7. Svensjo T, Pomahac B, Yao F, Slama J, Eriksson E. Accelerated healing of full-thickness skin wounds in a wet environment. Plast Reconstr Surg 2000;106:602-12.
8. Sullivan TP, Eaglstein WH, Davis SC, Mertz P. The pig as a model for human wound healing. Wound Repair Regen 2001;9:66-76.
9. Eaglstein WH, Mertz PM. "Inert" vehicles do affect would healing. J Invest Dermatol 1980;74:90-1.
10. Pope LE, Marcelletti JF, Katz LR, Lin JY, Katz DH, Parish ML, et al. The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process. Antiviral Res 1998;40:85-94.
11. Katz DH, Marcelletti JF, Khalil MH, Pope LE, Katz LR. Antiviral activity of 1-docosanol, an inhibitor of lipid-enveloped viruses including herpes simplex. Proc Natl Acad Sci U S A 1991;88:10825-9.
12. Khalil MH, Marcelletti JF, Katz LR, Katz DH, Pope LE. Topical application of docosanol- or stearic acid-containing creams reduces severity of phenol burn wounds in mice. Contact Dermatitis 2000;43:79-81.
13. Awan AR, Harmenberg J, Flink O, Field HJ. Combinations of antiviral and anti-inflammatory preparations for the topical treatment of herpes simplex virus assessed using a murine zosteriform infection model. Antivir Chem Chemother 1998;9:19-24.
14. Spruance SL, McKeough MB. Combination treatment with famciclovir and a topical corticosteroid gel versus famciclovir alone for experimental ultraviolet radiation-induced herpes simplex labialis: a pilot study. J Infect Dis 2000;181:1906-10.